Helus pharma

Index
Globenewswire

Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder

Globenewswire

Helus Pharma Mengangkat Michael Cola sebagai Chief Executive Officer untuk Memimpin Fase Peningkatan Skala dan Eksekusi Berikutnya

Globenewswire

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution